Reuters logo
BRIEF-T2 Biosystems, Cidara Therapeutics enter partnership for commercial placement of T2Dx instruments
September 6, 2017 / 3:31 PM / 3 months ago

BRIEF-T2 Biosystems, Cidara Therapeutics enter partnership for commercial placement of T2Dx instruments

Sept 6 (Reuters) - T2 Biosystems:

* Co, Cidara Therapeutics entered into exclusive partnership for commercial placement of T2Dx instruments to support CD101 drug trials​

* Program is designed to accelerate enrollment in Cidara’s CD101 trials and to increase uptake of T2’s products. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below